The University of Chicago Header Logo

Connection

Mark Kozloff to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Molecular Targeted Therapy.
Mark Kozloff
Connection Strength
0.138
Molecular Targeted Therapy
  1. A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.